HIGHLIGHTS
- who: Report and colleagues from the Pulmonary and Critical Care Medicine, BronxCare Health System, Icahn School of Medicine at Mount Sinai, Bronx, USA have published the research: Review began 07/19/2022 Review ended 07/23/2022 Published 07/26/2022 © Copyright, in the Journal: (JOURNAL) of July/26,/2022
- what: Physicians need to be aware of the detrimental course and poor prognosis associated with hepatic and renal amyloidosis.
- future: Some studies have shown that patients with hepatic amyloidosis have a high score of liver stiffness on fibroscan however further studies are needed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.